SMS Pharmaceuticals Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Attractively valued vs sector (P/E 37.9x vs industry 50.2x)
- Low debt relative to equity (D/E 0.5x)
Concerns
- Trading near 52-week high (₹494)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SMSPHARMA · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 64.32% | 64.67% | 64.67% | 64.67% | 64.67% | 66.27% |
| FII | 0.59% | 0.17% | 0.18% | 0.52% | 0.31% | 0.08% |
| DII | — | 1.98% | 2.13% | 2.55% | 2.55% | 2.43% |
| Public | 35.10% | 33.18% | 33.03% | 32.27% | 32.47% | 31.23% |
Latest News
All newsSMS Pharmaceuticals receives new credit rating
*SMS Pharmaceuticals receives new credit rating.* The company has been assigned a credit rating as per a regulatory filing on the NSE. Details include short-term and long-term debt assessment by the rating agency. The rating reflects stable outlook with **'IND AA+'** for long-term and **'IND A1+'** for short-term. 📊 *STOCKS:* SMSLTD | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CreditRating
SMS Pharmaceuticals sees spurt in trading volume
*SMS Pharmaceuticals sees spurt in trading volume* — SMS Pharmaceuticals witnessed a significant increase in trading volume, prompting the NSE to seek clarification. The company has responded to the exchange’s query to ensure transparency. No major corporate announcement was disclosed. 📊 *STOCKS:* SMSLTD | 🏢 *SECTOR:* Pharma | #LOWIMPACT #VolumeSpurt
SMS Pharma shares: AGM voting results disclosed
*SMS Pharma shares: AGM voting results disclosed*. SMS Pharmaceuticals has filed the scrutinizers' report of its Annual General Meeting held on **September 29, 2026**, with the stock exchange. The company disclosed the voting outcomes for all resolutions. No major corporate actions or surprises were reported. 📊 *STOCKS:* $SMSL | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM
SMS Pharma to host analyst and investor meet.
*SMS Pharma to host analyst and investor meet.* The company has announced a schedule for its upcoming analyst and institutional investor meet. This event aims to provide updates on business performance and strategic outlook. Such meets typically offer clarity but do not signal immediate operational changes. 📊 *STOCKS:* $SMSL | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Pharma
SMS Pharma releases sustainability report for FY25-26
*SMS Pharma releases sustainability report for FY25-26*. SMS Pharmaceuticals Limited has filed its Business Responsibility and Sustainability Report for FY2025-26. The report outlines the company's ESG initiatives and sustainable business practices. While informative, it contains no financial or operational updates. 📊 *STOCKS:* $SMSLTD | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Sustainability
SMS Pharma to hold shareholder meeting on Sep 29
*SMS Pharma to hold shareholder meeting on Sep 29* as per a corporate filing. The agenda and details will be announced closer to the date. Such meetings typically cover board elections, auditors, or policy approvals. No immediate financial impact expected. 📊 *STOCKS:* $SMSL | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholdersMeeting
SMS Pharma shifts 38th AGM date
*SMS Pharma shifts 38th AGM date.* The company has rescheduled its 38th Annual General Meeting to a new date. The revised schedule is now available in the NSE filing. No financial or operational changes were disclosed. 📊 *STOCKS:* $SMSL | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM
SMS Pharma informs on TDS on dividend payout
*SMS Pharma informs on TDS on dividend payout.* The company has issued an intimation regarding tax deduction at source on dividend payments as per applicable regulations. This is a routine compliance update with no immediate financial impact. Investors should note the standard TDS provisions on dividend income. 📊 *STOCKS:* $SMSLTD | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Dividend